FAQ

A Transjugular Intrahepatic Portosystemic Shunt (TIPS) is a minimally invasive procedure used to treat complications of portal hypertension. A small channel is created within the liver to redirect blood flow and reduce pressure in the portal vein. It is commonly used for conditions such as recurrent variceal bleeding or difficult-to-manage ascites.

Transarterial Chemoembolisation (TACE) is a targeted treatment for certain liver cancers, most commonly hepatocellular carcinoma. It involves delivering chemotherapy directly to the tumour through its blood supply, followed by embolisation to reduce blood flow to the tumour while treatment takes effect.

TACE is usually recommended for patients with liver cancer that is confined to the liver and where liver function is relatively preserved. Each patient’s suitability is carefully assessed during a multidisciplinary team discussion.

Ablation is a local treatment that destroys liver tumours using heat or energy, such as radiofrequency or microwave ablation. It is typically used for smaller tumours and may offer a curative option in selected cases or be used as a bridge to transplantation.

Eligibility for liver transplantation depends on the underlying liver condition, disease severity, overall health, and specific clinical criteria. Patients with advanced liver disease or selected liver cancers may be considered following a comprehensive assessment by a transplant team.

Patients should be referred early if they have decompensated cirrhosis, complications of liver disease, or liver cancer that may meet transplant criteria. Early referral allows time for full evaluation and optimisation.

All complex cases are reviewed at weekly multidisciplinary meetings involving hepatologists, surgeons, radiologists, and oncologists. This collaborative approach ensures that each patient receives an individualised, evidence-based treatment plan.

Yes. The Liver Centre accepts referrals for second opinions, particularly for complex liver conditions, to support informed decision-making and optimal patient care. For any other questions, please contact us here.